Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Article | IMSEAR | ID: sea-199680

ABSTRACT

Background: Nanosuspension technology has been developed as a promising candidate for efficient delivery of hydrophobic drugs. It could maintain the required crystalline state of the drug with reduced particle size, leading to an increased reporting on dissolution rate and therefore improved bioavailability.Methods: In this paper, we report on the preparation of Tamoxifen nanosuspension by high-pressure homogenization (HPH). The aim is to obtain a stable nanosuspension with an increased drug saturation solubility and dissolution velocity. The morphology and particle size distribution of the modified nanosuspensions were characterized by the means of several analyses that included: transmission electron microscopy (TEM), polarized light microscopy (PLM), scanning electron microscopy, differential scanning calorimetry (DSC) and powder X- ray diffractometry (XRD).Results: HPH was employed to produce aqueous drug nanosuspensions with fine solubility and dissolution properties, which render the produced particles stable up to one month. In addition, the prepared nanosuspensions possessed a high drug-loading efficiency (10%). The recoded zeta potential values (? -27 mV) indicated that the prepared nanosuspensions possess a higher degree of long-term stability. TEM data showed narrow size distribution with average size 322.7 nm. Morphologically, as indicated from results, the produced nanosuspensions have a homogenous distribution even after redispersion, indicating the stability of the product.Conclusions: It was possible to obtain Tamoxifen nanosuspensions with fine solubility and dissolution properties. Nanosuspensions possessed a high drug- loading (10%), which could reduce the dosage administration and gastrointestinal side effects. HPH can be employed to produce aqueous drug nanosuspensions that are stable up to one month. Aqueous nanosuspension can be converted to dry nanocrystals by lyophilization which offer superior physicochemical properties.

2.
Article in English | IMSEAR | ID: sea-157613

ABSTRACT

Drug-related hepatotoxicity is a serious health problem, with broad implications for patients, healthcare providers, the pharmaceutical industry and governmental regulatory agencies. Herein we report a rare case of amoxycillinclavulanic acid combination induced liver injury of cholestatic pattern in 40 years old, well educated male patient. Patient gave history that though other drugs were given to him by his physician for fever with chills & rigors, malaise, bodyache, except amoxycillin-clavulanic acid combination all other drugs were well tolerated previously by the patient, without appearance of jaundice. So jaundice in this patient was most probably due to amoxycillinclavulanic acid combination. Though severe liver injury is rare, proper history should be taken while prescribing amoxycillin-clavulanic acid combination. Attention must be paid to potential side-effects of the drugs and close follow-up with patients is a medical necessity to evaluate adverse reactions, especially in case of amoxycillinclavulanic acid combination.


Subject(s)
Adult , Amoxicillin-Potassium Clavulanate Combination/administration & dosage , Amoxicillin-Potassium Clavulanate Combination/adverse effects , Amoxicillin-Potassium Clavulanate Combination/toxicity , Chemical and Drug Induced Liver Injury/chemically induced , Chemical and Drug Induced Liver Injury/epidemiology , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/therapy , Humans , Jaundice/chemically induced , Jaundice/epidemiology , Jaundice/etiology , Jaundice/therapy , Liver/drug effects , Liver/pathology , Liver/toxicity , Male
3.
Article in English | IMSEAR | ID: sea-157376

ABSTRACT

The quinolones are generally well tolerated. The adverse reactions of quinolones include gastrointestinal symptoms, which are the most frequent, neuropsychiatric symptoms, hematologic abnormalities and less frequently, hypersensitivity skin reactions. Herein we report a case of 13 years old boy, who was suffering from upper respiratory tract infection and was treated with ofloxacin by a private practitioner and developed hypersensitivity reaction, one hour after taking ofloxacin tablet. Hospitalization and treatment of patient was carried out. Since hypersensitivity reaction to ofloxacin is rare, proper history of drug reactions should be taken while prescribing ofloxacin. Attention must be paid to potential side-effects of the drug while prescribing any medication, and close follow-up with patients is a medical necessity to evaluate for these adverse reactions, especially with quinolones.


Subject(s)
Child , Fluoroquinolones/administration & dosage , Fluoroquinolones/adverse effects , Humans , Hypersensitivity/epidemiology , Hypersensitivity/etiology , Male , Ofloxacin/administration & dosage , Ofloxacin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL